MedTrace Logo

To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors

NCT01199224 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2017-11-21

No results posted yet for this study

Summary

Compare the bioavailability of three veliparib formulations in subjects with solid tumors.

Conditions

Interventions

DRUG

veliparib

veliparib formulation A

DRUG

veliparib

veliparib formulation B

DRUG

veliparib

veliparib formulation C

DRUG

veliparib

veliparib formulation C

Sponsors & Collaborators

Principal Investigators

  • Bhardwaj Desai, MD · Abbott

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199224 on ClinicalTrials.gov